The role of Nanog expression in tamoxifen-resistant breast cancer cells

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• Cancerresearchuk.org [homepage on the internet]Cancer Research UK2013 [updated April 25, 2013; cited February 9, 2014]. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/incidence/uk-breast-cancer-incidence-statisticsAccessed May 10, 2014
   Google Scholar
• SchiffRMassarwehSShouJOsborneCKBreast cancer endocrine resistance how growth factor signaling and estrogen receptor coregula-tors modulate responseClin Cancer Res200391447S454S12538499
   PubMed Web of Science ®Google Scholar
• García-BecerraRSantosNDíazLCamachoJMechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistanceInt J Mol Sci20131410814523344024
   PubMed Web of Science ®Google Scholar
• ThraneSLykkesfeldtAELarsenMSSorensenBSYdeCWEstrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signalingBreast Cancer Res Treat20131391718023609470
   PubMed Web of Science ®Google Scholar
• DiehnMChoRWLoboNAAssociation of reactive oxygen species levels and radioresistance in cancer stem cellsNature2009458723978078319194462
   PubMed Web of Science ®Google Scholar
• VisvaderJELindemanGJCancer stem cells in solid tumours: accumulating evidence and unresolved questionsNat Rev Cancer200881075576818784658
   PubMed Web of Science ®Google Scholar
• VezzoniLPermianGLimitations of the cancer stem cell theoryCytotechnology20085813919002771
   PubMed Web of Science ®Google Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A200310073983398812629218
   PubMed Web of Science ®Google Scholar
• Ben-PorathIThomsonMWCareyVJAn embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumorsNat Genet20084049950718443585
   PubMed Web of Science ®Google Scholar
• LiuHZhangHWSunXFTamoxifen-resistant breast cancer cells possess cancer stem-like cell propertiesChin Med J (Engl)2013126163030303423981606
   PubMed Web of Science ®Google Scholar
• JeterCRBadeauxMChoyGFunctional evidence that the self-renewal gene NANOG regulates human tumor developmentStem Cells2009275993100519415763
   PubMed Web of Science ®Google Scholar
• FidalgoMFaiolaFPereiraCFZfp281 mediates Nanog auto-repression through recruitment of the NuRD complex and inhibits somatic cell reprogrammingProc Natl Acad Sci U S A201210940162021620722988117
   PubMed Web of Science ®Google Scholar
• MengHMZhengPWangXYOverexpression of nanog predicts tumor progression and poor prognosis in colorectal cancerCancer Biol Ther20109429530220026903
   PubMed Web of Science ®Google Scholar
• GuTTLiuSYZhengPSCytoplasmic NANOG-positive stromal cells promote human cervical cancer progressionAm J Pathol2012181265266122683467
   PubMed Web of Science ®Google Scholar
• ChambersISilvaJColbyDNanog safeguards pluripotency and mediates germline developmentNature200745071731230123418097409
   PubMed Web of Science ®Google Scholar
• NohKHKimBWSongKHNanog signaling in cancer promotes stem-like phenotype and immune evasionJ Clin Invest2012122114077409323093782
   PubMed Web of Science ®Google Scholar
• ShanJShenJLiuLNanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinomaHepatology20125631004101422473773
   PubMed Web of Science ®Google Scholar
• CroceCMOncogenes and cancerN Engl J Med2008358550251118234754
   PubMed Web of Science ®Google Scholar
• BrabletzTTo differentiate or not – routes towards metastasisNat Rev Cancer201212642543622576165
   PubMed Web of Science ®Google Scholar
• PhillipsTMMcBrideWHPajonkFThe response of CD24−/low/CD44+ breast cancer–initiating cells to radiationJ Natl Cancer Inst200698241777178517179479
   PubMedGoogle Scholar
• LiXLewisMTHuangJIntrinsic resistance of tumorigenic breast cancer cells to chemotherapyJ Natl Cancer Inst2008100967267918445819
   PubMedGoogle Scholar
• LingGQChenDBWangBQZhangLSExpression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell linesOncol Lett201241264126823197999
   PubMed Web of Science ®Google Scholar
• ClaytonHTitleyIVivancoMdGrowth and differentiation of progenitor/stem cells derived from the human mammary glandExp Cell Res2004297244446015212947
   PubMed Web of Science ®Google Scholar
• RingADowsettMMechanisms of tamoxifen resistanceEndocr Relat Cancer200411464365815613444
   PubMed Web of Science ®Google Scholar
• DaidoneMGLuisiAVeneroniSBeniniESilvestriniRClinical studies of Bcl-2 and treatment benefit in breast cancer patientsEndocr Relat Cancer199961616810732789
   PubMed Web of Science ®Google Scholar
• LiangYYanCSchorNFApoptosis in the absence of caspase 3Oncogene200120456570657811641782
   PubMed Web of Science ®Google Scholar
• SalamiSKarami-TehraniFBiochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell linesClin Biochem200336424725312810152
   PubMed Web of Science ®Google Scholar
• MandlekarSYuRTanTHKongANActivation of caspase-3 and c-Jun NH2-terminal kinase-1 signalling pathways in tamoxifen-induced apoptosis of human breast cancer cellsCancer Res200060215995600011085519
   PubMed Web of Science ®Google Scholar
• DawsonSJMakretsovNBlowsFMBCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedBr J Cancer2010103566867520664598
   PubMed Web of Science ®Google Scholar
• YangQSakuraiTJingXExpression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinomaPathol Int199949977578010504548
   PubMed Web of Science ®Google Scholar
• García-BecerraRSantosNDíazLCamachoJMechanisms of resistance to endocrine therapy in breast cancer: focus on signalling pathways, miRNAs and genetically based resistanceInt J Mol Sci201214110814523344024
   PubMed Web of Science ®Google Scholar
• LiuWSwetzigWMMedisettyRDasGMEstrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cellsPloS One2011612e2946622216287
   PubMed Web of Science ®Google Scholar
• KumarRVadlamudiRKAdamLApoptosis in mammary gland and cancerEndocr Relat Cancer20007425726911174847
   PubMed Web of Science ®Google Scholar
• ZhangGJKimijimaIOndaMTamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levelsClin Cancer Res19995102971297710537367
   PubMed Web of Science ®Google Scholar
• OsborneCKHobbsKTrentJMBiological differences among MCF-7 human breast cancer cell lines from different laboratoriesBreast Cancer Res Treat1987921111213620713
   PubMed Web of Science ®Google Scholar
• PivaMDomeniciGIriondoOSox2 promotes tamoxifen resistance in breast cancer cellsEMBO Mol Med201461667924178749
   PubMed Web of Science ®Google Scholar